Cargando…
Pathologic and prognostic impacts of FGFR2 amplification in gastric cancer: a meta-analysis and systemic review
Fibroblast growth factor receptor-2 (FGFR2) gene is amplified in up to 15% of patients with gastric cancer (GC). However, the prognostic significance of FGFR2 amplification has been controversial. This meta-analysis was conducted to evaluate the clinicopathological impacts of FGFR2 amplification in...
Autores principales: | Kim, Hyeong Su, Kim, Jung Han, Jang, Hyun Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584337/ https://www.ncbi.nlm.nih.gov/pubmed/31258762 http://dx.doi.org/10.7150/jca.29184 |
Ejemplares similares
-
Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis
por: Kim, Hyeong Su, et al.
Publicado: (2019) -
Prognostic impact of high c-Met expression in ovarian cancer: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2018) -
FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro
por: Cha, Yongjun, et al.
Publicado: (2018) -
KRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review
por: Kim, Bum Jun, et al.
Publicado: (2016) -
FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis
por: Kim, Jung Han, et al.
Publicado: (2021)